This is posted elsewhere, but it is worth considering on the eve of a Yes/No FDA APPROVAL for Ryoncil if you are wondering what plan B, C and D are. Importantly, Plan B/C/D are all substantially more financially significant for the company than Ryoncil approval for Pediatric SRaGVHD is.
The first 50 minutes explains the progress that has been made over the last 20 years in the treatment of heart failure, with various stem cell products including some from Mesoblast and culminates in the Doc talking about the Mesoblast phase 3 trial and how it is a trial for product approval to the FDA.
He talks about the data unblinding due in May 2020, and that if there were very positive results, the results would be published around August September 20. ( this was pre-covid )
He also says if it's not very positive that the results would come out in at the American heart association meeting - which is scheduled to be an online event November 13-17 2020.
What can we take out of this? The phase 3 reveal should occur prior to or during the Nov 13 -17th date. ie...... within about 50 days.
American Heart Association Meeting:
https://exhibitatsessions.org/scientific-sessions/
Heart Failure Readout - Just around the corner
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |